BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10653903)

  • 1. [Delineation of 6q deletions in breast carcinoma cell lines by fluorescence in situ hybridization].
    Zhang Y; Zhou J; Weng L; Gu W
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Feb; 17(1):20-3. PubMed ID: 10653903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of 6q deletions in breast carcinoma cell lines by fluorescence in situ hybridization.
    Zhang Y; Matthiesen P; Siebert R; Harder S; Theile M; Scherneck S; Schlegelberger B
    Hum Genet; 1998 Dec; 103(6):727-9. PubMed ID: 9921911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 3-cM commonly deleted region in 6q21 in leukemias and lymphomas delineated by fluorescence in situ hybridization.
    Zhang Y; Matthiesen P; Harder S; Siebert R; Castoldi G; Calasanz MJ; Wong KF; Rosenwald A; Ott G; Atkin NB; Schlegelberger B
    Genes Chromosomes Cancer; 2000 Jan; 27(1):52-8. PubMed ID: 10564586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of candidate tumor-suppressor genes in 6q27 by combined deletion mapping and electronic expression profiling in lymphoid neoplasms.
    Steinemann D; Gesk S; Zhang Y; Harder L; Pilarsky C; Hinzmann B; Martin-Subero JI; Calasanz MJ; Mungall A; Rosenthal A; Siebert R; Schlegelberger B
    Genes Chromosomes Cancer; 2003 Aug; 37(4):421-6. PubMed ID: 12800155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of 6q deletion in Waldenstrom macroglobulinemia.
    Chang H; Qi X; Xu W; Reader JC; Ning Y
    Eur J Haematol; 2007 Sep; 79(3):244-7. PubMed ID: 17655703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a dual-color fluorescence in situ hybridization probe set on chromosome 6q to improve cytogenetic diagnosis of lymphoid malignancies.
    Crowley JA; Butler MS; Ronnenburg MJ; Ament CN; Meekins JS; Ning Y
    Cancer Genet Cytogenet; 2005 Feb; 157(1):78-81. PubMed ID: 15676153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization evaluation of chromosome deletion patterns in prostate cancer.
    Huang SF; Xiao S; Renshaw AA; Loughlin KR; Hudson TJ; Fletcher JA
    Am J Pathol; 1996 Nov; 149(5):1565-73. PubMed ID: 8909246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia.
    Stilgenbauer S; Bullinger L; Benner A; Wildenberger K; Bentz M; Döhner K; Ho AD; Lichter P; Döhner H
    Leukemia; 1999 Sep; 13(9):1331-4. PubMed ID: 10482982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome band 6q deletion pattern in malignant lymphomas.
    Taborelli M; Tibiletti MG; Martin V; Pozzi B; Bertoni F; Capella C
    Cancer Genet Cytogenet; 2006 Mar; 165(2):106-13. PubMed ID: 16527604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of 6q16-q21 in human lymphoid malignancies: a mapping and deletion analysis.
    Jackson A; Carrara P; Duke V; Sinclair P; Papaioannou M; Harrison CJ; Foroni L
    Cancer Res; 2000 Jun; 60(11):2775-9. PubMed ID: 10850412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combined strategy of conventional cytogenetics, fluorescent in situ hybridization and microsatellite polymerase chain reaction to analyze the deletion of chromosome 6 in laryngeal squamous cell carcinoma.
    Kang N; Li F; Fu W; Zhang J; Sun K
    Oncol Rep; 2007 Dec; 18(6):1379-85. PubMed ID: 17982620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delineation of the minimal region of loss at 13q14 in multiple myeloma.
    Elnenaei MO; Hamoudi RA; Swansbury J; Gruszka-Westwood AM; Brito-Babapulle V; Matutes E; Catovsky D
    Genes Chromosomes Cancer; 2003 Jan; 36(1):99-106. PubMed ID: 12461754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.
    van Gils W; Kilic E; Brüggenwirth HT; Vaarwater J; Verbiest MM; Beverloo B; van Til-Berg ME; Paridaens D; Luyten GP; de Klein A
    Melanoma Res; 2008 Feb; 18(1):10-5. PubMed ID: 18227702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6q deletion detected by fluorescence in situ hybridization using bacterial artificial chromosome in chronic lymphocytic leukemia.
    Dalsass A; Mestichelli F; Ruggieri M; Gaspari P; Pezzoni V; Vagnoni D; Angelini M; Angelini S; Bigazzi C; Falcioni S; Troiani E; Alesiani F; Catarini M; Attolico I; Scortechini I; Discepoli G; Galieni P
    Eur J Haematol; 2013 Jul; 91(1):10-9. PubMed ID: 23560441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Array comparative genomic hybridization reveals a very high frequency of deletions of the long arm of chromosome 6 in testicular lymphoma.
    Bosga-Bouwer AG; Kok K; Booman M; Boven L; van der Vlies P; van den Berg A; van den Berg E; de Jong B; Poppema S; Kluin P
    Genes Chromosomes Cancer; 2006 Oct; 45(10):976-81. PubMed ID: 16865685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of 6q27 in chronic lymphocytic leukemia and multiple myeloma detected by fluorescence in situ hybridization.
    Amiel A; Mulchanov I; Elis A; Gaber E; Manor Y; Fejgin M; Lishner M
    Cancer Genet Cytogenet; 1999 Jul; 112(1):53-6. PubMed ID: 10432937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion 6q is not a characteristic marker of nodal lymphoplasmacytic lymphoma.
    Cook JR; Aguilera NI; Reshmi S; Huang X; Yu Z; Gollin SM; Abbondanzo SL; Swerdlow SH
    Cancer Genet Cytogenet; 2005 Oct; 162(1):85-8. PubMed ID: 16157207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast.
    Tibiletti MG; Sessa F; Bernasconi B; Cerutti R; Broggi B; Furlan D; Acquati F; Bianchi M; Russo A; Capella C; Taramelli R
    Clin Cancer Res; 2000 Apr; 6(4):1422-31. PubMed ID: 10778973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6q deletion discriminates Waldenström macroglobulinemia from IgM monoclonal gammopathy of undetermined significance.
    Schop RF; Van Wier SA; Xu R; Ghobrial I; Ahmann GJ; Greipp PR; Kyle RA; Dispenzieri A; Lacy MQ; Rajkumar SV; Gertz MA; Fonseca R
    Cancer Genet Cytogenet; 2006 Sep; 169(2):150-3. PubMed ID: 16938573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular cytogenetic analysis of the breakpoint region at 6q21-22 in T-cell lymphoma/leukemia cell lines.
    Tagawa H; Miura I; Suzuki R; Suzuki H; Hosokawa Y; Seto M
    Genes Chromosomes Cancer; 2002 Jun; 34(2):175-85. PubMed ID: 11979551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.